NCT05860179 Examination of Trends in Multiple Myeloma Trial Patient Experiences Status NOT_YET_RECRUITING Phase N/A
NCT05860036 A Study of VRd-based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With New-diagnosed Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05858203 Inhibition of Che-1/AATF as a New Tool in Multiple Myeloma Treatment Status RECRUITING Phase N/A
NCT05855122 Safety and ASCT-related Symptom Burden Optimization of Tocilizumab in ASCT Following HD Melphalan Conditioning for Multiple Myeloma Patients Status UNKNOWN Phase PHASE4
NCT05853965 Combination Treatment of Belantamab Mafodotin and Venetoclax in Treatment of Relapsed and Refractory t(11;14) Multiple Myeloma Status RECRUITING Phase PHASE1/PHASE2
NCT05850286 A Study of VRd-based Regimen Combined With CART-ASCT-CART2 Treatment in NDMM Patients With P53 Abnormalities Status RECRUITING Phase PHASE2
NCT05846880 VitD3 Supplementation in Patients With Multiple Myeloma Status RECRUITING Phase EARLY_PHASE1
NCT05846737 BCMA CAR-T Cell Therapy in High-risk NDMM Patients With Positive MRD After First-line ASCT Status WITHDRAWN Phase PHASE2
NCT05841550 The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma Status RECRUITING Phase PHASE1/PHASE2
NCT05835726 Daratumumab-containing Induction Effects on Stem Cells Mobilization, colLection and Engraftment in Newly Diagnosed Multiple MyelomA Patients. Status COMPLETED Phase N/A
NCT05833737 Corneal Findings in Patients Treated With Belantamab Mafodotin Status TERMINATED Phase N/A
NCT05831358 Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program Status ACTIVE_NOT_RECRUITING Phase NA
NCT05828511 A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment Status RECRUITING Phase PHASE1/PHASE2
NCT05827016 A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma Status RECRUITING Phase PHASE3
NCT05823571 Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients Status ACTIVE_NOT_RECRUITING Phase PHASE1